TYMP and cancer: Elevated levels of ROS are a common hallmark of cancer progression and have been detected in cancer cells due to an increase in metabolic activity, cellular signaling, activation of oncogenes, and increased enzymatic activity of oxidases (including cyclooxygenases, lipoxygenases, and thymidine phosphorylases).